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Abstract
Background While 3D laparoscopy increases surgical performance under laboratory conditions, it is unclear whether it 
improves outcomes in real clinical scenarios. The aim of this trial was to determine whether the 3D laparoscopy can enhance 
surgical efficacy in laparoscopic cholecystectomy (LCC).
Method This prospective randomized controlled study was conducted between February 2015 and April 2017 in a day case 
unit of an academic teaching hospital. Patients scheduled for elective LCC were assessed for eligibility. The exclusion criteria 
were: (1) planned secondary operation in addition to LCC, (2) predicted to be high-risk for conversion, and (3) surgeons with 
less than five previous 3D laparoscopic procedures. Patients were operated on by 12 residents and 3 attendings. The primary 
endpoint was operation time. All surgeons were tested for stereoaquity (Randot® stereotest). The study was registered in 
ClinicalTrials.gov (NCT02357589).
Results A total of 210 patients were randomized; 105 to 3D laparoscopy and 104 to 2D laparoscopy. Median operation time 
as similar in the 3D and 2D laparoscopy groups (49 min vs. 48 min, p = 0.703). Operation times were similar in subgroup 
analyses for surgeon’s sex (male vs. female), surgeon’s status (resident vs. attending), surgeon’s stereovision (stereopsis 10 
vs. less than 10), surgeon’s experience (performed 200 LCCs or below versus over 200 LCCs), or patient’s BMI (≤ 25 vs. 
25–30 vs. > 30). No differences in intra- or postoperative complications were noted between the 3D and 2D groups.
Conclusion 3D laparoscopy did not show any advantages over 2D laparoscopy in LCC.
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Laparoscopy has become the gold standard for many abdomi-
nal operations, and the spectrum is increasing all the time 
with the inclusion of more and more complex operations 
[1–3]. The technological evolution has been tremendous, 
however, since the beginning of the laparoscopic era, the lack 
of depth in operative field visualization has been a limitation. 
A three-dimensional (3D) operative field is visualized on a 
two-dimensional (2D) screen, which needs to be converted 
back to a 3D field in the surgeon’s brain. The first laparo-
scopes with 3D capability were introduced in the 1990s, but 
enthusiasm quickly subsided as they caused disturbing side-
effects in surgeons such as visual strain and headache [4].
Recently, modern high-definition 3D laparoscopes have 
emerged and are used in many hospitals. Although they 
make visual depth available, these systems have several 
negative aspects as well. First, the laparoscopes are 10 mm 
in size, compared to the possibility to use 5 mm 2D laparo-
scopes, and 10 mm 3D laparoscopes might thus cause poten-
tial risk for port site hernias. On the other hand, atleast one 
5 mm port site needs to be enlarged to extract the specimen. 
Second, specific glasses need to be worn for the duration of 
the operation, and the 3D monitor is more prone to visual 
disturbances if the positioning is not optimal. Third, 3D 
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laparoscopes are more expensive than their 2D counterparts 
and thus this economic burden needs to be justified if it is to 
be applied routinely in clinical practice.
Several experimental studies have shown benefit of 3D in 
terms of operative times, but circumstances are not equiva-
lent to clinical settings [5].
Laparoscopic cholecystectomy (LCC) is one of the most 
common procedure in general surgery and is usually car-
ried out as a day case surgery. A few randomized trials have 
tried to evaluate the benefits of 3D laparoscopy in LCC, but 
the conclusions are limited by the small number of patients 
included in the trials.
The aim of this study was to compare the surgical efficacy 
and safety of 3D versus 2D laparoscopy in LCC.
Materials and methods
This was a randomized controlled trial conducted in the day 
surgery department of an academic teaching hospital func-
tioning also as a secondary referral center (HUS Helsinki 
University Hospital). Patients scheduled for elective LCC in 
an operating room equipped with 3D laparoscopic instrumen-
tation were assessed for eligibility. Patients could be included 
if they were scheduled for an elective LCC for symptomatic 
cholecystolithiasis. The exclusion criteria were: (1) planned 
secondary operation in addition to LCC, (2) predicted to be 
high-risk for conversion to laparotomy (such as history of 
numerous abdominal operations, peritonitis, or acute chol-
ecystitis within the previous 3 months), and (3) surgeons 
with inadequate experience in 3D laparoscopy (defined as 
less than five 3D laparoscopic procedures). The set limit used 
to determine adequate experience for the 3D procedures was 
based on an earlier report indicating that the learning curve 
for 3D laparoscopy included five procedures [6].
Power calculation and randomization
The primary outcome measure was operation time. Sec-
ondary outcome measures included conversion rate, intra-
operative complications, postoperative complications (Cla-
vien–Dindo), need for hospital stay, estimated blood loss, 
hospital readmission, mortality, and operation room time. For 
power calculation purposes, the operation time for LCC pro-
cedures performed in 2013 in the department were extracted 
from the electronic operating room scheduling board. The 
cases for inclusion in this calculation were searched using 
ICD-10 code JKA21 as the primary procedure in the year 
2013. Cases with a secondary procedure code were excluded. 
The mean operative time for LCC was 56.5 min [standard 
deviation (SD) 25.5  min, n = 521]. Standard deviations 
were assumed to be similar in the forthcoming 3D proce-
dures. Based on these figures, 80% power, 0.05 alpha, 1:1 
allocation, and two-tailed power analyses were performed. 
The study was powered to detect 10 min differences in opera-
tive procedures by including 208 patients. A block randomi-
zation with a 1:1 allocation and a randomly varied block size 
of 4 to 6 was generated using Blockrand 1.1 package with 
R Statistical Software. Randomization cards were enclosed 
in sequentially numbered, opaque-sealed envelopes. At the 
time of inclusion, the envelopes were opened sequentially by 
the operating surgeon prior to the operation. Patients were 
blinded to their randomization group.
Instrumentation and interventions
Wolf® (Richard Wolf Medical Instruments®, Chicago, 
Illinois, USA) 2D/3D laparoscopic HD device with a non-
deflectable 30◦ scopes were used for all the operations. The 
system can display both 3D and 2D images. For the 3D 
group cases, the device was set to 3D, and for the 2D group it 
was set to 2D. The surgeons were allowed to switch from 3D 
to 2D if needed, (e.g., during trocar insertion) but switching 
from 2D to 3D in the 2D group was not allowed. Adherence 
to the randomized group (2D or 3D) was assessed by a case 
report form, which the surgeon filled after the operation. In 
the 3D group, the surgeons and an assistant standing on the 
patients left side wore passive polarizing glasses through the 
whole operation, whereas no extra glasses were worn in the 
2D cases. Both the surgeon and the assistant used the same 
monitor, which was located on the patients’ right side. The 
surgeons were allowed to define the proper viewing position 
for themselves to avoid any disturbances in vision.
Residents performing the operations had at least 3 years sur-
gical experience and were on rotation at the day case surgery 
unit. Residents, if deemed proficient, were allowed to perform 
LCC procedures independently. The number of previous pro-
cedures (LCC or 3D procedures in general) were recorded for 
each surgeon (classified as < 50, > 50, or > 200 previous cases 
for LCC; < 10, > 10, or > 50 previous cases for 3D procedures 
in general). The subjective satisfaction of each surgeon was 
collected based on a 0–10 Likert scale score, and the surgeons 
were free to express comments or concerns regarding the lapa-
roscope in free-text form after the operation. The stereo acuity 
was measured using the Randot® Stereotest (Stereo Optical, 
Chicago, Illinois, USA), but surgeons were neither selected 
nor excluded based on the test. The Randot test consists of ten 
sets of three circles, one of which has a crossed disparity and 
appears to be closer. Between the sets the disparity decreases 
from 400 to 20 s of arc. If the surgeon could not distinguish 
the differences between the sets, he/she was considered stereo 
blind (0 points). Otherwise the level of stereopsis was defined 
as the last circle identified correctly. The level of perfect stere-
opsis was defined to 20 s of arc (10 points).
The operation time was defined as the time from the first 
incision until closure of the skin. A standard LCC in this 
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study included the insertion of four trocars, one 12-mm tro-
car inserted supraumbilically, one 10-mm trocar inserted 
in the epigastric region, and two 5-mm trocars inserted in 
the right flank. Routinely, the fundus of the gallbladder was 
grasped, Calot’s triangle was dissected revealing the critical 
view of safety, and the gallbladder was detached from the 
liver using a monopolar hook. The gallbladder was extracted 
through the epigastric incision. After extraction, the abdomi-
nal cavity was checked to ensure hemostasis. Drains were 
not used. Surgeons were allowed to deviate from these rou-
tines if deemed necessary for patient safety.
Thirty-day complications were assessed from the electronic 
medical records, and the patients were contacted by phone at 
30 days after the operation. At that time, post-discharge com-
plications were assessed. In cases where the patient did not 
respond to phone calls, they were contacted by letter.
Statistical analysis
The statistical analyses were performed using SPSS® ver-
sion 22 (IBM, Armonk, NY). Continuous variables were 
compared between groups using the Mann–Whitney U test 
and p values < 0.05 were considered statistically significant. 
Subgroup analyses based on the sex of the surgeon, the sur-
geon’s level of experience, resident versus attending status, 
and stereovision were specified a priori, and additionally 
subgroup analysis was performed for patients’ body mass 
index (BMI).
This study was approved by the institutional review board 
and the ethical board of Helsinki University Hospital. All 
patients gave informed written consent to participate the 
study. The study was registered in ClinicalTrials.gov before 
randomization (NCT02357589).
Results
A total of 276 patients were assessed for eligibility begin-
ning February 2015. Randomization to the LCC trial reached 
209 patients by April 2017 (Fig. 1).
There were no differences in the patients’ basic character-
istics between the 3D and 2D groups (Table 1). The majority 
Fig. 1  CONSORT flow-chart of patient selection, randomization, and follow-up
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had no other health issues. Patients were operated on by 12 
residents and 3 attendings with variable experience in lapa-
roscopic cholecystectomy (Table 1). Two surgeons (13%) 
were stereo blind. One operation was converted from 3D to 
2D due to dysfunction of the light cable.
One 3D laparoscopy was converted to open cholecystec-
tomy due to chronic cholecystitis. There were no conversion 
to open surgery in the 2D laparoscopy group. No differ-
ences were noted in intraoperative or postoperative com-
plications (Table 2). All postoperative complications were 
Clavien–Dindo class 1 or 2, with no differences between the 
3D and 2D groups. Three patients (1.6%; n = 3 in 3D, n = 0 
in 2D) were readmitted and 38 (19.9%; n = 17 in 3D, n = 21 
in 2D) had an outpatient visit within 30 days.
None of the patients died within 90 days after the opera-
tion. Although scheduled in a day case surgical unit, 20 
patients (19.0%) in the 3D arm and 17 patients (16.3%) in 
the 2D arm required an overnight stay in hospital mostly due 
to social issues.
The time spent in the operating room and operation time 
were similar in 3D and 2D arms (Table 2). There were no 
differences in operation times within the subgroup analysis 
based on the sex of the surgeon, surgeon’s level of experi-
ence, status (resident / attending), stereovision, or patient’s 
Table 1  Basic characteristic 
of patients undergoing 
laparoscopic cholecystectomy 
and of the surgeons operating 
on them N (%)
2D two-dimensional, 3D three-dimensional, ASA The American Society of Anesthesiologists physical sta-
tus classification, BMI body mass index, IqR interquartile range, LCC laparoscopic cholecystectomy
3D (n = 105) 2D (n = 104)
Age, median; IqR 48.5; 56.4–24.7 49.9; 38.2–59.3
BMI, median; IqR 28.4; 31.9–25.1 27.3; 31.0–24.7
Male patient 31 (29.5%) 27 (26.0%)
ASA-classification
 1 37 (35.2%) 47 (45.2%)
 2 60 (57.1%) 49 (47.1%)
 3 8 (7.6%) 8 (7.7%)
Charlson’s comorbidity index
 0 97 (92.4%) 100 (96.2%)
 1 6 (5.7%) 2 (1.9%)
 2 2 (1.9%) 1 (1.0%)
 3 0 1 (1.0%)
History of earlier abdominal operation(s)
 Open 4 (3.8%) 3 (2.9%)
 Laparoscopic 9 (8.6%) 12 (11.5%)
Indication
 Symptomatic gallbladder stones 100 (95.2%) 98 (94.2%)
 Earlier pancreatitis and gallbladder stones 1 (1.0%) 0
 Gallbladder and bile duct stones 2 (1.9%) 0
 Gallbladder polyp 2 (1.9%) 2 (1.9%)
 Other 0 (1.0%) 2 (1.9%)
 Earlier cholecystitis 0 2 (1.9%)
Surgeon
 Man 89 (84.8%) 94 (90.4%)
 Attending 66 (62.9%) 64 (61.5%)
 Resident 39 (37.1%) 40 (38.5%)
Surgeon experience in LCC, cases
 < 50 2 (1.9%) 4 (3.8%)
 50–200 46 (43.8%) 37 (35.6%)
 > 200 57 (54.3%) 63 (60.6%)
Surgeon experience in 3D laparoscopy, cases
 5–10 19 (18.1%) 14 (13.5%)
 10–50 53 (50.5%) 58 (55.8%)
 > 50 33 (31.4%) 32 (30.8%)
Surgeon stereo acuity, stereopsis 10 74 (70.5%) 80 (76.9%)
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body mass index (Table 3). Attendings had similar satis-
faction in 3D and 2D groups, but residents preferred 3D 
laparoscopy (Table 2).
Discussion
Clinical studies regarding 3D laparoscopy are scarce with 
low numbers of patients and surgeons. We conducted a pro-
spective randomized controlled study to clarify the role of 
3D laparoscopy in terms of surgical efficacy and safety dur-
ing one of the most common laparoscopic operation, LCC. 
To our knowledge, this was the largest study evaluating 3D 
on LCC. However, we did not find any benefit of 3D lapa-
roscopy in performing LCC.
The first clinical report comparing 3D and 2D lapa-
roscopy was a small randomized trial with 30 patients in 
each group that underwent LCC and were operated on by 
four experienced surgeons [4]. Similar to our results, no 
differences in operating times was found. Contrary to our 
results, the surgeons were dissatisfied with 3D laparoscopy 
complaining of visual strain, headache and physical discom-
fort. We found nearly maximal satisfaction with 3D laparos-
copy among both attendings and residents. Residents were 
actually significantly more satisfied with 3D. The study by 
Hanna et al. was carried out in 1998 and laparoscopic instru-
mentation has evolved since. Newer studies with high-defini-
tion 3D laparoscopes have not reported surgeon discomfort 
during 3D laparoscopy [7, 8].
A recent systematic review evaluating 3D laparoscopy in 
general included thirteen randomized controlled studies, of 
which only two were clinical trials including a total of 162 
patients [5]. One of these trials assessed 3D in vesicoureteral 
anastomosis and found no difference in regards to time to 
complete anastomosis compared to 2D laparoscopy [7]. 
Another trial reported decrease of operative time in mini-
gastric bypass, but not in sleeve gastrectomy when using 
3D compared to 2D laparoscopy [9]. Most of the studies 
Table 2  Outcome measures after laparoscopic cholecystectomy
IqR interquatile range, LCC laparoscopic cholecystectomy, SD standard deviation
*Five patients had more than one complication
3D n = 105 2D n = 104 p value
Operating room time, minutes, median; IqR 112.0; 100.0–128.0 108.5; 96.3–124.3 0.261
Operation time, minutes, median; IqR 49.0; 39.0–65.0 48.0; 38.5–59.8 0.703
Estimated blood loss, ml, mean (SD) 4.8 (13.3) 11.9 (60.9) 0.245
Intraoperative complications
 None 91 (86.7%) 89 (85.4%) 0.843
 Gallbladder rupture 7 (6.7%) 10 (9.7%)
 Intraoperative bleeding, minor 4 (3.8%) 4 (3.9%)
 Bleeding, liver bed, haemostat needed 2 (1.9%) 1 (1.0%)
 Iatrogenic lesion (liver cyst) 1 (1.0%) 0
Postoperative complication*
 Total 21 (22.3%) 22 (22.7%) 0.731
 Clavien–Dindo I 15 (16.0%) 12 (12.4%) 0.537
  Abnormal pain 9 (9.6%) 3 (3.2%)
  Urinary retention 2 (1.9%) 0
  Bleeding (abdominal wall) 0 3 (3.2%)
  Postoperative fever, (liver bed hematoma) 1 (1.0%) 0
  Dizziness 0 1 (1.0%)
  Nausea 0 1 (1.0%)
  Gastroenteritis 0 1 (1.0%)
  Respiratory infection 0 1 (1.0%)
  Other 3 (3.2%) 2 (1.9%)
 Clavien–Dindo II 6 (6.4%) 10 (10.3%) 0.435
  Surgical wound infection 6 (6.4%) 7 (7.2%)
  Thrombophlebitis from iv canula 0 2 (1.9%)
  Vaginal candidiasis 0 1 (1.0%)
Satisfaction with laparoscopic view, attendings, median; IqR 10; 10 10; 9–10 0.259
Satisfaction with laparoscopic view, residents, median, IqR 9; 8–10 8; 7–8 < 0.001
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(eleven) in the systematic review were experimental, in 
which 3D was either equal or superior to 2D laparoscopy. 
The systematic review concluded that these findings need to 
be validated in larger clinical trials.
A few randomized trials assessing 3D in LCC have been 
published. Komaei et al. [10] conducted a systematic review 
and found only five randomized controlled trials compar-
ing 2D to 3D in LCC reporting all together 209 patients 
[10]. Three of these trials reported a significant reduction in 
operative time in 3D LCC [9, 11, 12], while two did not find 
such difference [4, 13]. The systematic review concluded 
that bigger cohort sizes are needed to assess 3D laparoscopy 
and justify the increased costs of new, more expensive 3D 
systems.
This study has limitations. First, the study was not 
blinded from the surgeons’ side as this would have been 
impossible given the nature of the study. Second, no vali-
dated questionnaire to assess surgeons’ fatigue, nausea, 
or distress was used. The surgeons scaled their satisfac-
tion to the laparoscope on a Likert scale and were free to 
report any complaints as free text. Third, the time spent 
performing different tasks during the operation were not 
recorded. Therefore, we do not know whether some parts 
of the procedure have been faster with 3D. However, our 
primary outcome, whole operative time, is more practical. 
Fourth, the primary endpoint was operative time, and one 
could argue that better endpoints in a clinical trial would 
have been morbidity and mortality. However, these were 
included as secondary endpoints, but this study was not 
powered to detect differences in major complications or 
mortality, as these are very rare events in elective LCC. 
There were no hints that these would be altered by the 3D 
or 2D approach.
The strength of this study is large sample size. Large 
numbers of patients and surgeons were involved with vari-
ous levels of expertise allowing a subgroup analyses to be 
performed. The study designs were rather pragmatic, and 
as such, the results are highly applicable to daily practice.
In our study, three-dimensional laparoscopy does not 
improve surgical efficacy of elective LCC. There were no 
differences between 3D and 2D in terms of surgical safety, 
and it seems unlikely that any clinically relevant differ-
ences will be found even if larger trials would be carried 
out.
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